Table 1.
Demographics and Opioid Behaviors by Naloxone Strength Preferences
| Overall (N=11 52) | Indifference (n=558; 48.4%) | Prefer High Dose (n=413; 35.9%) | Prefer Standard Dose (n=125; 10.9%) | Neither (n=56; 4.9%) | |
|---|---|---|---|---|---|
| Age M (SD) | 33.6 (10.1) | 34.4 (9.9) | 32.7 (10.0) | 33.0 (10.8) | 33.9 (11.5) |
| Gender %(n) | |||||
| Female | 27.5% (317) | 27.1% (151) | 29.1% (120) | 24% (30) | 28.6% (16) |
| Male | 72.3% (833) | 72.9% (407) | 70.7% (292) | 75.2% (94) | 71.4% (40) |
| Other | 0.2% (2) | 0% (0) | 0.2% (1) | 0.8% (1) | 0% (0) |
| Race %(n) | |||||
| Black or African American | 10.9% (126) | 12.4% (69) | 9.0% (37) | 9.6% (11) | 14.3% (8) |
| Asian | 0.8% (9) | 0.9% (5) | 0.2% (1) | 0.8% (1) | 3.6% (2) |
| American Indian or Alaskan Native | 1.0% (11) | 0.7% (4) | 1.5% (6) | 0% (0) | 1.8% (1) |
| Native Hawaiian or Pacific Islander | 0.2% (2) | 0% (0) | 0.2% (1) | 0% (0) | 1.8% (1) |
| Other | 8.7% (100) | 9.0% (50) | 6.1% (15) | 17.6% (22) | 5.4% (3) |
| White | 78.5% (904) | 77.1% (430) | 83.1% (343) | 72.0% (90) | 73.2% (41) |
| Ethnicity %(n) | |||||
| Non-Hispanic | 90.5% (1042) | 8.4% (47) | 8.0% (33) | 17.6% (22) | 14.3% (8) |
| Hispanic | 9.5% (110) | 91.6% (511) | 92.0% (380) | 82.4% (103) | 85.7% (48) |
| Level of Care %(n) | |||||
| Medically Managed Inpatient | 66.3% (764) | 75.8% (423) | 55.7% (230) | 58.4% (73) | 67.9% (38) |
| Residential | 27.9% (321) | 19.0% (106) | 36.3% (150) | 38.4% (48) | 30.4% (17) |
| IOP | 5.8% (67) | 5.2% (29) | 8.0% (33) | 3.2% (4) | 1.8% (1) |
| Carries Naloxonea %(n) | 57.3% (660) | 55.2% (308) | 62.0% (256) | 66.4% (83) | 23.2% (13) |
| Narcan | 53.6% (618) | 53.6% (299) | 55.9% (231) | 61.6% (77) | 19.6% (11) |
| Naloxone Nasal Spray | 4.1% (47) | 1.4% (8) | 6.3% (26) | 9.6% (12) | 1.8% (1) |
| Intramuscular | 4.3% (49) | 2.2% (12) | 7.3% (30) | 4.0% (5) | 3.6% (2) |
| Evzio | 1.0% (12) | 0.2% (1) | 2.2% (9) | 1.6% (2) | 0% (0) |
| Other | 1.6% (18) | 0.4% (2) | 2.9% (12) | 2.4% (3) | 1.8% (1) |
| Overdose History %(n) | 53.9% (621) | 46.1% (257) | 63.9% (264) | 64.8% (81) | 33.9% (19) |
| Past Month Suspected Fentanyl Exposure %(n) | 72.5% (835) | 76.0% (424) | 73.6% (304) | 64.0% (80) | 48.2% (27) |
| Has Ever Been Administered Naloxone %(n) | 48.4% (558) | 42.7% (238) | 55.2% (228) | 59.2% (74) | 32.1% (18) |
| # of Doses of Narcan Administered in Most Recent Reversal b | |||||
| 1 Dose | 20.6% (115) | 20.2% (48) | 18.0% (41) | 29.7% (22) | 22.2% (4) |
| 2 or More Doses | 59.9% (334) | 60.9% (145) | 59.2% (135) | 59.5% (44) | 55.6% (10) |
| Do Not Know | 19.5% (109) | 18.9% (45) | 22.8% (52) | 10.8% (8) | 22.2% (4) |
Note. Presented are percentage (cell sample size) for naloxone strength preferences for administration to self. Mean = M
a
Carry refers to any product, respondents could endorse more than one.
b
Responses only for respondents with a history of naloxone administration